Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis.
Saved in:
| Title: | Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis. |
|---|---|
| Authors: | Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. chiasiang_93@hotmail.com., Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia. |
| Source: | Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2021 Jul; Vol. 52 (1), pp. 124-129. Date of Electronic Publication: 2021 Apr 04. |
| Publication Type: | Letter; Meta-Analysis |
| Journal Info: | Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-742X (Electronic) Linking ISSN: 09295305 NLM ISO Abbreviation: J Thromb Thrombolysis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
